1h Free Analyst Time
The field of synthetic injectable bone grafts has emerged as a pivotal domain within regenerative medicine, offering minimally invasive solutions for skeletal repair and augmentation. As traditional grafting techniques evolve, clinicians are increasingly turning to injectable alternatives that promise enhanced biocompatibility, controlled resorption, and optimized handling characteristics. This introduction sets the stage by examining the confluence of demographic pressures, procedural innovations, and material science breakthroughs that have elevated injectable bone grafts from niche applications to mainstream clinical adoption. By outlining core drivers-such as the rise in orthopedic procedures among aging populations, the demand for shorter recovery times, and the need for personalized implant solutions-this section underscores why injectable grafts represent both a technological leap and a commercial opportunity. Furthermore, the integration of bioactive compounds and tailored polymer matrices has not only improved osteoconductivity but also expanded the potential indications across craniomaxillofacial, dental, and spine surgeries. As we transition into a detailed exploration of market shifts and strategic imperatives, this segment provides the foundational context for understanding how synthetic injectable bone grafts are reshaping surgical outcomes and redefining competitive dynamics within the biomaterials industry.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts Reshaping Injectable Bone Grafting
Over the past decade, the landscape of bone grafting has been marked by transformative shifts that have propelled injectable formulations to the forefront. Key among these is the shift from rigid, preformed devices toward adaptable injectable matrices that conform to complex defect geometries without secondary shaping. Concurrently, advanced manufacturing technologies such as additive manufacturing and microfluidic encapsulation have enabled precise control over pore architecture and growth factor distribution. These innovations facilitate accelerated bone ingrowth while minimizing patient morbidity. Regulatory frameworks have also evolved to accommodate minimally invasive delivery systems, with streamlined pathways introducing novel materials at a faster pace. In parallel, surgeons have adopted image-guided delivery techniques, enhancing accuracy and reducing operative times. The convergence of these trends has not only heightened clinical confidence but also stimulated increased investment by medical device companies and venture capitalists. As a result, the market witnesses a broadening competitive landscape, where established biomaterial suppliers vie alongside agile startups deploying next-generation injectable calcium phosphate and polymer composites. This section unpacks these transformative shifts, illustrating how technological, regulatory, and clinical practice changes collectively redefine the future of bone regeneration.Cumulative Impact of United States Tariffs 2025
The introduction of new tariff regimes in the United States in 2025 has had a cumulative impact on the synthetic injectable bone graft market, influencing supply chains, manufacturing costs, and pricing strategies. Raw materials such as specialty polymers and calcium phosphate precursors, which are often sourced from overseas suppliers, have seen duty increases that erode margin structures. In response, manufacturers have accelerated localization efforts, forming strategic partnerships with domestic suppliers and investing in in-house compounding facilities to mitigate exposure to import levies. At the same time, trade policy uncertainty has compelled distributors to revise inventory management protocols, shifting from just-in-time ordering toward buffer stocking, thereby increasing working capital requirements. Clinicians and health systems, facing the prospect of higher procedure expenditures, have become more cost-conscious, scrutinizing reimbursement codes and seeking bundle arrangements to manage overall treatment costs. Despite these headwinds, companies that have diversified their regional production footprints-leveraging free trade agreements in neighboring markets-continue to maintain competitive pricing. Ultimately, the 2025 tariffs have underscored the importance of resilient supply chains and adaptive pricing models, prompting industry stakeholders to recalibrate growth strategies for a more protectionist trade environment.Key Segmentation Insights Across Six Dimensions
A nuanced understanding of market segmentation delivers critical insights into product development and commercialization strategies. When categorized by material type, injectable bone grafts encompass allograft variants including frozen and liquid formats, composite materials such as bioactive glass and hydroxyapatite composites, synthetic materials spanning poly methyl methacrylate and tricalcium phosphate, and xenografts derived from bovine and porcine origins. Each material class exhibits distinct performance characteristics, with synthetic polymers offering customizable degradation rates and xenografts facilitating natural extracellular matrix integration. Examining the market by end user reveals differentiated adoption curves across academic institutes-specifically medical schools and research centers-alongside dental and orthopedic clinics and both private and public hospitals, each driven by unique procedural volumes and patient demographics. In terms of application, the spectrum ranges from craniomaxillofacial surgery addressing cranial defects and facial augmentation, to dental implantology and periodontal surgery, and orthopedic interventions such as spinal fusion and trauma fixation. Form factor segmentation highlights blocks and moldable constructs, granular formats that vary in pore size, liquid systems available in injectable and non-injectable options, and putty formulations designed for intraoperative handling preferences. Procedure type further dissects the market into laser-assisted hard and soft tissue applications, minimally invasive arthroscopic and endoscopic techniques, and open surgical approaches covering advanced and traditional methodologies. Finally, resorbability considerations distinguish between fully and partially bioresorbable grafts versus permanent non-resorbable materials, each aligning with specific clinical protocols and healing timeframes. Together, these segmentation insights equip decision-makers with a comprehensive framework to tailor product portfolios and market entry strategies.Key Regional Insights Driving Market Dynamics
Regional dynamics play a pivotal role in shaping growth trajectories and adoption patterns. In the Americas, established reimbursement frameworks and high procedure volumes drive demand, with North America remaining the largest market due to robust infrastructure and early technology adoption. Latin American markets, while smaller, demonstrate increasing interest as government healthcare spending rises. Across Europe, the Middle East & Africa, regulatory harmonization under CE marking and Gulf Cooperation Council initiatives streamline market access, yet heterogeneous healthcare budgets and tender processes create varying uptake speeds from Western Europe’s advanced hospitals to emerging markets in Eastern Europe and the Levant. The Asia-Pacific region exhibits the fastest acceleration, fueled by expansive public hospital networks in China and India, supportive government policies promoting domestic manufacturing, and a growing pool of trained specialists. Southeast Asia and Australasia follow closely, driven by medical tourism and private sector investment in state-of-the-art surgical centers. These regional insights underscore the importance of tailoring market strategies to local regulatory landscapes, reimbursement environments, and clinical practice norms to capture growth opportunities effectively.Competitive Landscape and Leading Market Players
Competitive positioning within the injectable bone graft market reflects a mix of global conglomerates and specialized innovators. Established biomaterials frontrunners such as DePuy Synthes (a Johnson & Johnson company), Medtronic plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc. leverage extensive distribution networks and comprehensive R&D pipelines. Mid-sized players including Baxter International Inc., Bioventus LLC, and Integra LifeSciences Holdings Corporation focus on differentiated formulations and targeted clinical support programs to gain share in key segments. Niche specialists such as AlloSource, Collagen Matrix, Inc., Osiris Therapeutics, Inc., and RTI Surgical, Inc. capitalize on proprietary cell-based technologies and xenograft innovations. Orthofix Medical Inc., NuVasive, Inc., and Wright Medical Group N.V. diversify through strategic acquisitions and collaborations to expand their injectable portfolios. Meanwhile, Johnson & Johnson Services, Inc. amplifies its market reach by integrating regenerative solutions with digital surgical planning platforms. Across the board, leading companies emphasize strategic partnerships with academic institutions, investment in minimally invasive delivery systems, and dynamic pricing models to respond to evolving reimbursement pressures. This competitive overview highlights both consolidation trends and the emergence of disruptive entrants poised to challenge traditional market hierarchies.Actionable Recommendations for Industry Leaders
To navigate the complexities of the synthetic injectable bone graft market, industry leaders should pursue several actionable strategies. First, prioritize investment in R&D platforms that enable rapid prototyping of customizable injectable matrices, focusing on tunable degradation rates and bioactive agent integration to meet diverse surgical needs. Second, strengthen supply chain resilience by securing local raw material partnerships and exploring additive manufacturing capabilities, thereby mitigating import tariff exposures and reducing lead times. Third, forge alliances with key opinion leaders and academic centers to generate robust clinical evidence and facilitate early adopters’ evangelism, enhancing reimbursement negotiation leverage. Fourth, deploy digital tools such as surgical planning software and augmented reality guidance to differentiate product offerings and improve procedural accuracy, fostering long-term customer loyalty. Fifth, adopt flexible pricing models that align with value-based procurement trends, offering outcome-linked contracts or volume-based incentives. By executing these recommendations, companies can accelerate innovation cycles, bolster market access, and establish sustainable competitive advantages within a rapidly evolving regulatory and economic environment.Conclusion: Shaping the Future of Bone Regeneration
In conclusion, synthetic injectable bone grafts represent a transformative frontier in musculoskeletal regeneration, uniting advanced biomaterials science with minimally invasive delivery techniques. The market’s rapid evolution-driven by material innovations, regulatory adaptations, and shifting trade policies-requires stakeholders to adopt agile strategies encompassing R&D, supply chain optimization, and value-based commercialization. Segmentation insights across material types, end users, applications, forms, procedure types, and resorbability provide a detailed roadmap for targeted portfolio development. Regional analyses reveal diverse adoption patterns, highlighting the need for tailored market entry plans. Competitive dynamics underscore both the dominance of established players and the disruptive potential of emerging specialists. By embracing the recommended strategic imperatives, organizations can enhance clinical outcomes, navigate policy headwinds, and secure leadership positions within this high-growth domain.Market Segmentation & Coverage
This research report categorizes the Synthetic Injectable Bone Graft Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Allograft
- Frozen Allograft
- Liquid Allograft
- Composite Materials
- Bioactive Glass Composite
- Hydroxyapatite Composite
- Synthetic Materials
- Poly Methyl Methacrylate
- Tricalcium Phosphate
- Xenograft
- Bovine Origin
- Porcine Origin
- Academic Institutes
- Medical Schools
- Research Institutes
- Clinics
- Dental Clinics
- Orthopedic Clinics
- Hospitals
- Private Hospitals
- Public Hospitals
- Craniomaxillofacial Surgery
- Cranial Defects
- Facial Augmentation
- Dental Surgeries
- Implantology
- Periodontal Surgery
- Orthopedics
- Spinal Fusion
- Trauma Fixation
- Blocks and Moldable
- Non-Sintered Moldable Blocks
- Sintered Blocks
- Granules
- Macroporous Granules
- Microporous Granules
- Liquid Form
- Injectable Liquid
- Non-Injectable Liquid
- Putty
- Injectable Putty
- Non-Injectable Putty
- Laser-Assisted Procedures
- Hard Tissue Laser
- Soft Tissue Laser
- Minimally Invasive Surgery
- Arthroscopic Procedures
- Endoscopic Procedures
- Open Surgery
- Advanced Techniques
- Traditional Approach
- Bio-Resorbable Materials
- Fully Resorbable
- Partially Resorbable
- Non-Resorbable Materials
- Permanent Grafts
This research report categorizes the Synthetic Injectable Bone Graft Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Synthetic Injectable Bone Graft Market to delves into recent significant developments and analyze trends in each of the following companies:
- AlloSource
- Baxter International Inc.
- Bioventus LLC
- Collagen Matrix, Inc.
- DePuy Synthes (a Johnson & Johnson Company)
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson Services, Inc.
- Medtronic plc
- NuVasive, Inc.
- Orthofix Medical Inc.
- Osiris Therapeutics, Inc.
- RTI Surgical, Inc.
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Synthetic Injectable Bone Graft Market, by Material Type
8.1. Introduction
8.2. Allograft
8.2.1. Frozen Allograft
8.2.2. Liquid Allograft
8.3. Composite Materials
8.3.1. Bioactive Glass Composite
8.3.2. Hydroxyapatite Composite
8.4. Synthetic Materials
8.4.1. Poly Methyl Methacrylate
8.4.2. Tricalcium Phosphate
8.5. Xenograft
8.5.1. Bovine Origin
8.5.2. Porcine Origin
9. Synthetic Injectable Bone Graft Market, by End User
9.1. Introduction
9.2. Academic Institutes
9.2.1. Medical Schools
9.2.2. Research Institutes
9.3. Clinics
9.3.1. Dental Clinics
9.3.2. Orthopedic Clinics
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Synthetic Injectable Bone Graft Market, by Application
10.1. Introduction
10.2. Craniomaxillofacial Surgery
10.2.1. Cranial Defects
10.2.2. Facial Augmentation
10.3. Dental Surgeries
10.3.1. Implantology
10.3.2. Periodontal Surgery
10.4. Orthopedics
10.4.1. Spinal Fusion
10.4.2. Trauma Fixation
11. Synthetic Injectable Bone Graft Market, by Form
11.1. Introduction
11.2. Blocks and Moldable
11.2.1. Non-Sintered Moldable Blocks
11.2.2. Sintered Blocks
11.3. Granules
11.3.1. Macroporous Granules
11.3.2. Microporous Granules
11.4. Liquid Form
11.4.1. Injectable Liquid
11.4.2. Non-Injectable Liquid
11.5. Putty
11.5.1. Injectable Putty
11.5.2. Non-Injectable Putty
12. Synthetic Injectable Bone Graft Market, by Procedure Type
12.1. Introduction
12.2. Laser-Assisted Procedures
12.2.1. Hard Tissue Laser
12.2.2. Soft Tissue Laser
12.3. Minimally Invasive Surgery
12.3.1. Arthroscopic Procedures
12.3.2. Endoscopic Procedures
12.4. Open Surgery
12.4.1. Advanced Techniques
12.4.2. Traditional Approach
13. Synthetic Injectable Bone Graft Market, by Resorbability
13.1. Introduction
13.2. Bio-Resorbable Materials
13.2.1. Fully Resorbable
13.2.2. Partially Resorbable
13.3. Non-Resorbable Materials
13.3.1. Permanent Grafts
14. Americas Synthetic Injectable Bone Graft Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Synthetic Injectable Bone Graft Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Synthetic Injectable Bone Graft Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AlloSource
17.3.2. Baxter International Inc.
17.3.3. Bioventus LLC
17.3.4. Collagen Matrix, Inc.
17.3.5. DePuy Synthes (a Johnson & Johnson Company)
17.3.6. Integra LifeSciences Holdings Corporation
17.3.7. Johnson & Johnson Services, Inc.
17.3.8. Medtronic plc
17.3.9. NuVasive, Inc.
17.3.10. Orthofix Medical Inc.
17.3.11. Osiris Therapeutics, Inc.
17.3.12. RTI Surgical, Inc.
17.3.13. Stryker Corporation
17.3.14. Wright Medical Group N.V.
17.3.15. Zimmer Biomet Holdings, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SYNTHETIC INJECTABLE BONE GRAFT MARKET MULTI-CURRENCY
FIGURE 2. SYNTHETIC INJECTABLE BONE GRAFT MARKET MULTI-LANGUAGE
FIGURE 3. SYNTHETIC INJECTABLE BONE GRAFT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SYNTHETIC INJECTABLE BONE GRAFT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SYNTHETIC INJECTABLE BONE GRAFT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SYNTHETIC INJECTABLE BONE GRAFT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FROZEN ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIOACTIVE GLASS COMPOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE COMPOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY POLY METHYL METHACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BOVINE ORIGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PORCINE ORIGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MEDICAL SCHOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIAL DEFECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FACIAL AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PERIODONTAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-SINTERED MOLDABLE BLOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SINTERED BLOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MACROPOROUS GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MICROPOROUS GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-INJECTABLE LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-INJECTABLE PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HARD TISSUE LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SOFT TISSUE LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ARTHROSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ADVANCED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRADITIONAL APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FULLY RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PARTIALLY RESORBABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PERMANENT GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 163. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 165. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 166. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 167. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 168. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 170. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 171. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 174. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 175. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 176. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 177. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 178. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 179. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 180. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 181. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 182. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 183. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 184. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 185. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 186. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 187. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 189. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 190. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 191. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 192. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 204. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 205. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 206. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 207. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 208. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 209. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 210. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 211. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 212. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CRANIOMAXILLOFACIAL SURGERY, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BLOCKS AND MOLDABLE, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GRANULES, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LIQUID FORM, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LASER-ASSISTED PROCEDURES, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY OPEN SURGERY, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY RESORBABILITY, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BIO-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON-RESORBABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 290. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 291. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 292. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 293. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2030 (USD MILLION)
TABLE 294. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY XENOGRAFT, 2018-2030 (USD MILLION)
TABLE 295. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
TABLE 297. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 298. CHINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLIO
Companies Mentioned
- AlloSource
- Baxter International Inc.
- Bioventus LLC
- Collagen Matrix, Inc.
- DePuy Synthes (a Johnson & Johnson Company)
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson Services, Inc.
- Medtronic plc
- NuVasive, Inc.
- Orthofix Medical Inc.
- Osiris Therapeutics, Inc.
- RTI Surgical, Inc.
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
Methodology
LOADING...
